Nearly 44% of primary care visits for Medicare fee-for-service beneficiaries were telehealth visits in April, up from 0.1% in February, according to a report released this week by the Department of Health and Human Services.

Medicare fee-for-service telehealth visits for primary care climbed from about 14,000 per week before the COVID-19 pandemic to 1.3 million per week in April, HHS said.

The Centers for Medicare & Medicaid Services has waived Medicare geographic and originating site restrictions on telehealth and expanded the list of telehealth-eligible services and practitioners during the emergency.

HHS Secretary Alex Azar said the report “shows that Medicare providers and beneficiaries rapidly embraced these new opportunities. The meteoric rise of telehealth during the pandemic has not only helped us combat the virus, but also prompted a new conversation around the future of patient-centered care."

AHA has urged Congress and the Administration to ensure flexibilities remain in place after the public health emergency, as well as to reimburse virtual services on par with in-person care. For more information, see the new AHA factsheet on the future of telehealth.

Related News Articles

Headline
The Food and Drug Administration yesterday released FAQs describing the procedures for importing respirators, face masks, and other personal protective…
Headline
The departments of Health and Human Services and Defense will pay Moderna Inc. about $1.5 billion to produce and deliver 100 million doses of its COVID-19…
Headline
The Department of Health and Human Services yesterday announced it has expanded the providers eligible for its Public Health and Social Services Emergency Fund…
Headline
The Centers for Medicare & Medicaid Services today released a final report identifying best practices and potential solutions for reducing barriers in the…
Headline
Houston’s Kindred Healthcare and TIRR Memorial Hermann are among the many post-acute care providers that have incurred increased costs to prepare for and treat…
Headline
The Food and Drug Administration Friday authorized the emergency use of George Washington University Public Health Laboratory’s GWU SARS-CoV-2 RT-PCR Test. The…